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There have been several recent  hypotheses about the nature of the signals which cause 
activation of bursa-equivalent cells (B cells) during an immunological response (cf. 1). In 
one theory it was proposed that a single, antigen-specific signal induced B cells to produce 
antibodies (2). On the other hand, Coutinho et al. (3) suggested that activation of B cells 
was the result of one nonspecific signal which was mitogenic for B cells. In a third theory it 
was postulated that  two signals were required to activate B  cells to produce antibodies 
(4-8). These two signals were thought to be  (a)  the antigenic signal, or the binding of a 
specific immunodeterminant group to immunoglobulin-like receptors on the surface of a B 
cell and (b) a second, nonspecific signal. The second signal might have been some product 
of  antigen-activated  thymus-derived  cells  (T  cells)  in  the  case  of  T-cell  dependent 
antigens (9-22) or, as postulated for T-cell independent antigens, the second signal could 
have been associated with the antigen itself (8, 23-25). With respect to lipopolysaccharide 
(LPS), 1 a T-cell independent antigen (26-28), the second signal was reported to reside in 
the Lipid A  portion of the LPS  molecule (8,  29-32). 
Work in our laboratory has been directed toward investigating the immunological 
responses  of  mice  injected  with  LPS  (33,  34)  or  a  related  material,  native 
protoplasmic  polysaccharide (NPP)  (35). NPP,  extracted from the protoplasm of 
Escherichia coli (36,  37),  was a  simple polysaccharide with an average mQ1 wt of 
163,000  daltons  (38).  Once  thought  to  be  a  protoplasmic  precursor  to  cell wall 
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gamma globulin. 
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LPS  (36,  37),  NPP  was  more  recently  described  as  a  product  of  aberrant 
metabolism  (38).  Immunochemically,  the  O-antigenic  determinants  of  NPP 
cross-reacted completely with the O-antigenic  determinants  of homologous LPS 
(37, 39). However, NPP did not contain Lipid A, 2-keto-3-deoxyoctulosonate, or 
heptose, and failed to elicit some of the host reactive properties associated with 
LPS (37, 39). NPP was nontoxic for chicken embryos, nonpyrogenic for rabbits, 
and nonimmunogenic for rabbits (37,  39) and guinea pigs. ~ Also, NPP was found 
to  be  nonmitogenic  for  murine  spleen  cells  (31)  and,  in  the  presence  of 
homologous antiserum,  unable to fix complement (37, footnote 3). 
With the availability of the model system of immunochemically  homologous 
NPP  and  LPS,  experiments  were  designed  to  demonstrate  a  separation  of 
immunological  phenomena  which  might  be  attributed  to  a  separation  of 
immunological signals. This was achieved by showing that NPP (antigenic signal 
only) would stimulate mice to give a primary response and would sensitize mice 
for a secondary response, whereas LPS (antigenic signal and second signal) was 
necessary to trigger a secondary response. 
Materials  and  Methods 
Mice.  Mice of both sexes were obtained from the Rocky Mountain Laboratory (RML), Hamilton, 
Mont.  Congenitally  athymic  nude  mice  were  bred  in  our  laboratory  and  were  the  offspring  of 
heterozygous animals obtained by crossing nude males with RML females. In order to improve their 
general  health,  nude  mice  received water  containing oxytetracycline  (OTC,  Pharmaceutical Co., 
Karkov, Poland) and metronidazole (Flagyl, Searle & Co., Columbus, Ohio). Postmortem examina- 
tions confirmed that the nude mice used in the experiments were athymic. 
Antigens and Endotoxic Mitogens.  E. coli 0113 (Braude strain) and E. coli 0111:B4 (Difco strain) 
were  cultivated,  fractionated,  and  extracted  as  described  previously  (40).  Briefly,  the  cells were 
disrupted in a  refrigerated cell fractionator and the cell walls were separated from the protoplasmic 
fraction  by  differential  centrifugation.  LPS  from  E.  coli 0113  (LPS-0113)  and  E.  coli  0111:B4 
(LPS-0111) were extracted from the cell walls by the phenol-water procedure (41); NPP was extracted 
from  the  protoplasmic  fraction  of  E.  coli 0113  (NPP-0113)  with  cold  trichloroacetic  acid  (37). 
Glycolipid  was  extracted  by  the  phenol-water  procedure  (41)  from  whole  cells  of  Salmonella 
typhimurium  G30/C21 (ReGL-G30/C21) which is an Re mutant strain (42,  43). 
Bioassays revealed that the maximum possible contamination of NPP-0113 with LPS-0113 was 
less  than  1/5,000  by  weight.  Results  of  antigen  titration  studies  indicated  that  such  trace 
contamination of NPP-0113 by LPS-0113 could not account for the immunogenicity of NPP-0113. 
Lyophilized preparations of the materials described above were dissolved in phosphate-buffered 
saline (PBS-0.15 M  NaC1, 0.0033 M  PO,, pH 7.2) and stored at  20°C until used. All materials were 
injected intravenously (i.v.) via a  lateral tail vein. 
Immunoassays.  Standard  procedures  employing  sheep  erythrocytes  (SRBC)  coated  with 
LPS-0113 as indicator cells were used to determine the numbers of direct plaque-forming cells (PFC) 
(27) and titers of humoral antibodies (33). Humoral titers are expressed as values of x derived from 
the equation x  =  log2  (HD/2),  where HD  is the reciprocal of the highest dilution of serum which 
produced  hemagglutination of sensitized  SRBC  (34).  Thus,  the  titer  is  the  tube  number of the 
end-point when the first tube contains a  1/4 dilution of antiserum. Sera which gave no hemagglutina- 
tion at the lowest dilution tested were arbitrarily assigned a titer of 0,  i.e., a  dilution of 1A. 
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Results 
Kinetics of the Appearance of Antibodies  in Mice Injected with NPP-0113 or 
LPS-0113.  In order to quantitate the time of appearance of antibodies in mice 
injected with NPP-0113 or LPS-0113, groups of RML mice were injected with one 
dose (on day 0) or two doses (on days 0 and 21) of 1 ttg of antigen and were then 
bled on succeeding days. The kinetics of appearance of antibodies after both the 
primary and secondary injections of NPP-0113 or LPS-0113 are presented on Fig. 
1.  It  was  observed that the peak  titers to primary  injections of NPP-0113  and 
LPS-0113 were similar (4.6 and 5.6, respectively). However, LPS-0113 stimulated 









I--  5 
Z 
<  4 
0 
°°&°"l°"  •  i  ill  J" "'k'-~. 
LPS! 
....  .....  .....  ...... .  !  ,!  ...... 
i  •  /s~ 
:"  / 
•  t  • 
, ,A, • o'~/ 
--o  --e  l  I  I  I  I  I  I  l  I  I  I,  l  l  I  I 
2  4  b  8  10  12  14  16  18  20  22  24  26  28  30 
DAY 
2 o 
FIG.  1.  Kinetics  of  the  antibody  responses  of  RML  mice  injected  with  NPP-0113  or 
LPS-0113.  Each point represents  the titer  of sera pooled from  at  least five  mice. The bars 
indicate  the  range  of titers  observed  where  the  geometric  mean  titer  was calculated  from 
several experiments.  (O-nO),  antibody titers of mice injected i.v. with 1 t~g of NPP-0113 on 
days 0 and 21; (A..  • &), antibody titers of mice injected i.v. with 1 ttg of LPS-0113 on days 0 
and 21. 
differed  at the 99%  confidence levels)  than did NPP-0113.  Other differences  in 
the responses of mice to NPP-0113 and LPS-0113 were also noted after the second 
injections of antigen. The antibody response after a second dose of NPP-0113 was 
similar to the primary response to this antigen, whereas two doses of LPS-0113 
gave  a  typical  secondary  response.  These  observations  stimulated  further 
experimentation as described below. 
Requirement  for  LPS-0113  to  Trigger  a  Secondary  Response.  Repeated 
attempts  to  produce  a  secondary  response  with  different  doses  of  NPP-0113 
failed.  Therefore,  in an attempt to determine why NPP-0113 would not elicit a 
I 
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secondary response,  the following experiment was performed. Groups of RML 
mice were injected on day 0 with either 1 #g of NPP-0113,  1 ttg of LPS-0113, or 
PBS.  After  21  days,  some  mice  from  each  group  were  injected with  1 ttg  of 
NPP-0113,  1 ttg of LPS-0113, or with PBS.  Sera from mice in each group were 
collected  and  examined  for  antibodies  to  the  0113 determinant  by  passive 
hemagglutination and the splenic cells were assayed for specific anti-0113 PFC. 
Results of several experiments are compiled in Table I. It was found, again, that 
two  injections  of NPP-0113  would  not  stimulate  a  secondary response;  only 
another primary response was elicited. However,  mice primed with NPP-0113 
and challenged with the LPS-0113 responded by producing an antibody and PFC 
response similar quantitatively to the secondary responses of mice injected twice 
with  LPS-0113.  The  antibody responses  of mice  primed  with LPS-0113  and 
subsequently  challenged  with  NPP-0113  were  characteristically  primary  re- 
TABLE I 
Antibody  Responses of Mice to NPP-0113 and LPS-0113 
Primary injection  Secondary injection  Antibody titer  PFC/spleen$ 
(day 0)  (day 21)  (day 25)*  (day 25) 
PBS  PBS  0.4 (0-1.0)  20 
1 #g NPP-0113  PBS  3.0 (2.5-4.0)  40 
PBS  1 #g NPP-0113  3.9 (2.0-5.1)  100 
1 ttg NPP-0113  1 ttg NPP-0113  5.4 (4.0-6.5)  800 
1 #g NPP-0113  1 ttg LPS-0113  9.8 (8.0-11.0)  23,000 
PBS  1 #g LPS-0113  5.7 (4.0-7.0)  1,420 
1 #g LPS-0113  1 #g LPS-0113  10.0 (9.0-11.0)  19,200 
1 #g LPS-0113  1 #g NPP-0113  5.2 (3.2-8.0)  900 
* Geometric mean titer calculated from separate experiments (range in parentheses). 
Direct PFC/spleen from a single experiment. 
sponses,  similar  quantitatively to  the  responses  of  mice  injected  once  with 
LPS-0113.  These  results  showed  that  NPP-0113,  in  addition  to  eliciting  a 
primary response, sensitized mice for a secondary antibody response which could 
be triggered by LPS-0113. Therefore, the lack of a secondary response following 
two  doses  of  NPP-0113  did  not  result  from  a  lack  in  a  capacity  of  this 
polysaccharide  to  sensitize  the  mice;  NPP-0113  simply  could  not  trigger  a 
secondary response in mice sensitized with either NPP or LPS. 
Antibody  Responses  of Mice  Injected  with NPP-0113 Plus  a  Heterologous 
Endotoxic Mitogen.  Data presented above suggested that NPP possessed the 
attributes for primary sensitization of immunocompetent cells, but it lacked the 
second signal, which was necessary for triggering a  secondary response. Also it 
was shown that both signals were contained in the LPS. Therefore, an attempt 
was made to trigger a secondary response to the 0113 determinant by supplying 
the antigenic signal in the form of NPP-0113 and the second signal in the form of 
two non-cross-reacting endotoxic mitogens, LPS-0111 and ReGL-G30/C21, both 
of which contained Lipid A (43, 44). The results of one of these experiments are 
given  in  Table  II.  The  combination  of NPP-0113  and  different  amounts  of 1608  IMMUNOLOGICAL  RESPONSES  TO NPP AND LPS 
TABLE  II 
Antibody Responses  of Mice Injected with NPP-OI13 Plus a Heterologous 
Endotoxic Mitogen 
Primary injection  Secondary injection  Antibody titer* 
(day 0)  (day 21)  (day 25) 
1 ttg NPP-0113  1 ~g NPP-0113  5.0 
I ttg NPP-0113  1 ttg LPS-0113  9.0 
I ttg NPP-0113  i ttg NPP-0113 +  5 t~g LPS-0111  3.0 
1 ttgNPP-0113  1 ttg NPP-0113 + 10 ttg LPS-0111  4.5 
1 ttg NPP-0113  1 ttg NPP-0113 + 20 ttg LPS-0111  4.5 
1 ttg NPP-0113  1 #g NPP-0113 + 15 ttg ReGL-G30/C21  4.0 
1 ttg NPP-0113  1 #g NPP-0113 + 30 ttg ReGL-G30/C21  3.0 
1 ttg NPP-0113  1 ttg NPP-0113 + 60 ttg ReGL-G30/C21  5.5 
* Titer of sera pooled from five mice/group from a representative experiment. 
LPS-0111  or  ReGL-G30/C21  did  not  act  as  effective  stimuli  for  triggering  a 
secondary  response  in  mice which  were  primed  with  NPP-0113.  Other  experi- 
ments showed that  a  secondary response could not be stimulated  by NPP-0113 
and heterologous sources of Lipid A  in mice which were primed with LPS-0113. 
Thus,  to be effective in triggering a  secondary response,  apparently both signals 
had to be contained in the same molecule. 
Antibody Responses of Nude Mice Injected with NPP-0113.  Up to this point, 
the  immunological  behavior of NPP  appeared similar to that  of pneumococcal 
polysaccharide  (45)  and  polyvinylpyrrolidone  (46),  both  T-cell  independent 
antigens  (26,  27).  In  order  to  determine  whether  or  not  the  immunological 
responses  to  NPP  required  or  were  influenced  by  T  cells,  the  following 
experiments  were  performed.  Groups  of congenitally  athymic  nude  mice were 
injected  with  various  combinations  of  NPP-0113  and  LPS-0113,  and  their 
humoral  antibody  and  splenic  PFC  responses  were  quantitated.  The  data, 
presented in Table III, showed that a  single injection of NPP-0113  could elicit a 
weak  primary  response  in  nude  mice.  Slightly  higher  titers  were seen  in  nude 
mice  injected  twice  with  NPP-0113.  Most  importantly,  a  single  injection  of 
NPP-0113  sensitized  nude  mice  for  a  secondary  antibody  response  when 
challenged with LPS-0113.  In general,  the quantitative  patterns of the antibody 
responses of nude mice to NPP-0113 and LPS-0113 were similar to the patterns of 
responses  of  mice  possessing  T  cells.  It  was  concluded,  therefore,  that  the 
immunological  phenomena  observed  for  NPP-0113  were  independent  of  the 
influence of T  cells. 
Discussion 
Different  hypotheses  have  been  presented  to  suggest  mechanisms  for  the 
activation of B  cells by immunological signals (cf. 1). One current theory stated 
that  two  signals  were  required  to  activate  B  cells  to  secrete  antibodies  (4-8). 
However, the  individual  contribution  of each signal to the activation of B  cells 
has not been elucidated.  In the present report, functional  separation of the two KENNETH  B.  VON  ESCHEN  AND JON  A.  RUDBACH 
TABLE  III 
Antibody Responses of Nude Mice to NPP-OI13 and LPS-0113 
1609 
Primary injection*  Secondary injection  Antibody titer  PFC/spleen § 
(day 0)  (day 15)  (day 19)$  (day 19) 
PBS  PBS  0.0 (0-0)  ND 
PBS  1 ug NPP-0113  1.2 (0.0-3.0)  130 
1 ~g NPP-0113  1 ~g NPP-0113  4.3 (4.0-5.0)  460 
1 ~g NPP-0113  1 ~g LPS-0113  8.2 (7.0-9.0)  20,700 
PBS  1 ug LPS-0113  4.3 (2.0-6.0)  1,600 
1 #g LPS-0113  1 ~g LPS-0113  9.5 (7.0-11.0)  23,400 
1 ug LPS-0113  1 ~g NPP-0113  3.8 (3.0-5.0)  560 
* Three or four nude mice were included in each group. 
$ Geometric mean of titer calculated from titers  of individual mice from each group 
(range in parentheses). 
§ Spleens from mice of each group were pooled and tested for direct PFC against SRBC 
coated with LPS-0113. 
signals  required  for  induction  of  immune  responses  has  been  accomplished 
through  the  use  of  two  immunochemically  related,  but  biologically  distinct 
natural  products.  NPP-0113  did  not  contain  Lipid  A  (37-39),  was  unable  to 
activate complement even in the presence of homologous antibodies, (37, footnote 
3), was not mitogenic for splenic cells (31), and did not require T cells to mount an 
immune response (35 and Table III). Lipid A (8, 29, 30, 32), the third component 
of complement (6), or some product of antigen-activated T  cells (9-22) all have 
been suggested to act as the second signal during activation of B cells. Therefore, 
it appeared that NPP-0113 possessed only the antigenic signal. LPS-0113, on the 
other  hand,  contained  an  antigenic  signal  of  the  same  immunochemical 
specificity plus the second, nonspecific signal in the form of Lipid A. 
A  single  injection  of NPP-0113  elicited  a  normal  primary response  in  RML 
mice and a weak primary response in nude mice. This was shown repeatedly by 
the increase in humoral antibody titers and specific PFC. These results suggested 
that the antigenic signal alone could stimulate the B  cells of a  mouse to secrete 
antibodies. It was believed generally that initial contact between an antigen and 
the  immunocompetent cells of an animal caused this population of cells  (a)  to 
produce a  primary antibody response,  and (b) to expand in number so that the 
pool  of  cells  immunologically  specific  for  the  sensitizing  antigen  would  be 
increased  (47,  48).  Production  of  a  secondary  antibody  response  could  be 
explained  by  synthesis  of antibody  by  this  expanded  clone  of  cells.  In  this 
context, a single injection of NPP-0113 efficiently sensitized mice for a secondary 
response  which  could  be  triggered  by LPS-0113.  Therefore,  NPP-0113,  which 
possessed only the antigenic signal and not the mitogenic Lipid A (31), probably 
caused B  cells to proliferate and form an expanded clone of cells specific for the 
0113  immunodeterminant  group.  However,  this  expanded  clone of cells  must 
have been qualitatively different from the progenitor cells in the immunologically 
virgin animal,  because NPP-0113 could not trigger them to produce a secondary 
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What was discussed previously should not be interpreted to imply that a primary injection 
of NPP-0113 stimulated  exactly the same immunological events in an animal  as did a 
primary  injection  of LPS-0113.  In  fact,  a  comparison of the  kinetics  of the  primary 
responses to these two antigens shows that this probably was not the case.  The humoral 
antibody titer to LPS-0113 increased significantly faster than it did to the same dose of 
NPP-0113. Ultimately, however,  similar peak titers were reached. An explanation for this 
phenomenon might be that the mitogenicity associated with the Lipid A portion of the 
LPS-0113 enhanced the rate of cellular division or differentiation.  However, the actual 
numbers of antibody forming cells (reflected by the peak titer) was under the control of the 
antigenic signal. 
Data  from other studies  supported the concept that the antigenic signal alone might 
result in expansion O  f a specific clone of cells. For example, Chiller,  et al.  (49) found that 
mice  which  were  initially  tolerant  to  human  gamma  globulin  (HGG)  responded  in  a 
heightened fashion in comparison to mice which had not received the tolerogen, when both 
groups were challenged with an immunogenic preparation of HGG plus LPS. Apparently, 
the injection of the tolerogenic form of HGG (which was thought to contain the antigenic 
signal  only)  sensitized  mice for  an  enhanced  response  which  was  demonstrable  when 
tolerance was broken with LPS. The foregoing results were interpreted from the premise 
that the tolerogenic and antigenic signals were identical (4, 5). Even more direct evidence 
in support of the concept that the antigenic signal alone can generate an expanded clone of 
cells was given by H~inig, et al. (50). They noted that SRBC could stimulate proliferation 
of specific B cells in cultures of spleen cells derived from nude mice. In the absence of T 
cells,  the  SRBC  could  be  regarded  as  an  antigenic  signal  alone.  Thus,  the  results  of 
experiments with NPP-0113 were  in  concert with previous evidence indicating that the 
antigenic signal alone might cause the proliferation of a specific clone of B cells. 
Also, the foregoing data introduced a  new concept that two signals were required 
to trigger a specific secondary response in primed animals. This was shown by the 
requirement for LPS-0113 as the secondary stimulus; NPP-0113 (antigenic signal 
only)  could  elicit  only  another  primary  response  in  mice  primed  with  either 
NPP-0113  or  LPS-0113.  Other  T-cell  independent  antigens  such  as  Type  III 
pneumococcal polysaccharide (45) and polyvinylpyrrolidone (46) stimulated only 
primary  responses;  they  were  unable  to  elicit  secondary  responses.  The  data 
presented  above  would  tend  to  suggest  that  this  occurs not  because  Type III 
pneumococcal  polysaccharide  and  polyvinylpyrrolidone  could  not  prime  an 
animal,  but rather  because they lacked the second signal necessary to trigger a 
secondary response. That Type III pneumococcal polysaccharide and polyvinyl- 
pyrrolidone lack a second signal has been suggested previously by Watson, et al. 
(8). 
The finding that  mice primed with NPP-0113 and injected secondarily with NPP-0113 
plus  a  heterologous source of Lipid A  (LPS-0111 or ReGL-G30/C21) failed  to  make  a 
secondary  anti-0113  response  does  not  discredit  the  concept  that  both  signals  were 
required  to  trigger  a  secondary response.  Possibly,  both  the  antigenic  and  the  second 
signals were required on the same molecule so that both signals could contact the primed 
B cells simultaneously. Another explanation for the inability of a mixture of heterologous 
Lipid A and NPP-0113 to trigger a secondary response in primed mice could be that the 
binding of NPP-0113 to the immunoglobulin-like receptors on the surface of the B cells 
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moiety of the heterologous mitogen. A final possibility which should be considered was 
that  the  second  signal  might  have  been  given  by  something other  than  Lipid  A. 
Experiments  in progress should provide answers to some of these questions. 
In  conclusion,  we  would  like  to  make  the  following  suggestions:  both  the 
antigenic signal and the second signal play necessary, but distinct roles in the 
generation of immune responses. For the T cell independent antigens used in this 
study,  the  quantity  of antibodies  produced  during  a  primary  response  was 
dependent on  only the  amount of antigenic signal;  the  second  signal  simply 
accelerated the events leading to the peak primary response. A more important 
function of the second signal was the clearly demonstrable requirement for it to 
be associated with the antigenic signal in order to trigger a secondary response. 
Finally,  the  observation  that  the  single  antigenic  signal  could  stimulate 
unprimed  cells  to  secrete  antibodies,  whereas  both  signals  were  required  to 
trigger primed cells added to the evidence (33, 48, 51) indicating that qualitative, 
and not just quantitative differences have occurred at the cellular level during 
the generation of immunological memory. 
Summary 
Functional separation of the two signals involved in stimulating immunological 
responses  was  achieved  through  the  judicious  use  of  two  natural  bacterial 
antigens. Native protoplasmic polysaccharide (NPP) extracted from Escherichia 
coli was immunochemically identical to the lipopolysaccharide (LPS) extracted 
from the same organism. However, NPP was not endotoxic, not mitogenic, did 
not fix complement, and was immunologically independent of T cells. The NPP, 
which  appeared  to  contain only the  antigenic signal,  could  induce a  primary 
antibody response  in  mice and could sensitize mice for a  secondary response. 
However,  the  antigenic signal  contained in  NPP  was  insufficient to trigger a 
secondary response  in mice primed with either NPP or LPS. LPS, containing 
both  the  antigenic  and  second  signals,  was  required  to  trigger  a  secondary 
response in primed mice. 
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